Zobrazeno 1 - 10
of 426
pro vyhledávání: '"Boormans, J."'
Autor:
Klümper N; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; BRIDGE-Consortium Germany e.V., Mannheim, Germany., Tran NK; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Disease (NCT), University Hospital, Heidelberg, Germany., Hahn O; Department of Urology and Pediatric Urology, Julius Maximilians University Medical Center of Würzburg, Würzburg, Germany., Büttner T; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Roghmann F; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Department of Urology, Marien Hospital, Ruhr-University Bochum, Herne, Germany., Bolenz C; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany., Zengerling F; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany., Schwab C; Institute of Pathology, University of Heidelberg, Heidelberg, Germany., Nagy D; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Toma M; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Kristiansen G; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Heers H; Department of Urology, University Hospital Marburg, Marburg, Germany., Ivanyi P; Department of Hemostaseology, Oncology and Stem Cell Transplantation, Medical University Hannover, Hannover, Germany., Niegisch G; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany., Grunewald CM; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany., Darr C; Department of Urology, University Hospital Essen, Essen, Germany., Farid A; Department of Urology, University Medical Center Göttingen, Göttingen, Germany., Schlack K; Department of Urology, University Hospital Münster, Münster, Germany., Abbas M; Department of Pathology, University Hospital Münster, Münster, Germany., Aydogdu C; Department of Urology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Casuscelli J; Department of Urology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Mokry T; Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany., Mayr M; Clinic Ottakring, Institute of Pathology and Microbiology, Wien, Austria., Niedersüß-Beke D; Department of Internal Medicine I, Wilhelminenspital, Wien, Austria., Rausch S; Department of Urology, Eberhard Karls University, Tübingen, Germany., Dietrich D; Department of Otorhinolaryngology, University Medical Center Bonn (UKB), Bonn, Germany., Saal J; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Medical Center Bonn (UKB), Bonn, Germany., Ellinger J; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Ritter M; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; BRIDGE-Consortium Germany e.V., Mannheim, Germany., Alajati A; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Kuppe C; Institute of Experimental Medicine and Systems Biology and Division of Nephrology, RWTH Aachen University, Aachen, Germany., Meeks J; Department of Urology, Feinberg School of Medicine, Chicago, IL., Vera Badillo FE; Department of Medical Oncology, Queen's University, Kingston, Ontario, Canada., Nakauma-González JA; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Boormans J; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Junker K; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany., Hartmann A; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany., Grünwald V; Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, Interdisciplinary Genitourinary Oncology at the West-German Cancer Center, Essen University Hospital, Essen, Germany., Hölzel M; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Eckstein M; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 10; Vol. 42 (20), pp. 2446-2455. Date of Electronic Publication: 2024 Apr 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rutten, V. C., Salhi, Y., Robbrecht, G. J., de Wit, R., van Leenders, G. J.L.H., Zuiverloon, T. C.M., Boormans, J. L.
Supplementary Material 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288c4aeee720da5d860ddf913604c099
Autor:
Ripping, T. M., Rammant, E., Witjes, J. A., Aaronson, N. K., van Hemelrijck, M., van Hoogstraten, L. M.C., Boormans, J., Goossens, C. A., van der Heijden, A. G., Hulshof, M. C.C.M., van Leenders, G. J.L.H., van Leliveld, A. M., Meijer, R. P., van Moorselaar, R. J.A., Mulder, S. F., Nooter, R. I., Noteboom, J. L., Oddens, J. R., de Reijke, T. M., van Rhijn, B. W.G., van Roermund, J. G.H., Smilde, T. J., Vanderbosch, G. W.J., Wijsman, B. P., Kiemeney, L. A., Aben, K. K.H.
Publikováno v:
BlaZIB Study Group 2022, ' Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer ', Health and Quality of Life Outcomes, vol. 20, no. 1, 171 . https://doi.org/10.1186/s12955-022-02064-z
Health and quality of life outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20, 1
Health and Quality of Life Outcomes, 20
Health and quality of life outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20, 1
Health and Quality of Life Outcomes, 20
Background Quality of Life (QoL) of bladder cancer patients has been largely neglected. This is partly due to the lack of well-validated QoL questionnaires. The aim of this study is to examine the structural validity, reliability (i.e., internal cons
Autor:
Robbrecht, D., Koedoot, E., van der Meer, D., Ceton, L.J., Sijsenaar, T., Vader, W., Steinbusch, L., Steendam, C., Boormans, J., Ottevanger, P.B.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S771-S771
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Balar, A. V., Kamat, A. M., Kulkarni, G. S., Uchio, E. M., Boormans, J. L., Roumiguié, M., Krieger, L. E.M., Singer, E. A., Bajorin, D. F., Grivas, P., Seo, H. K., Nishiyama, H., Konety, B. R., Li, H., Nam, K., Kapadia, E., Frenkl, T., De Wit, R.
Publikováno v:
Journal of Urology, 208(1). Elsevier Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::daa84f23196a379dd20f5fd78642aa72
https://pure.eur.nl/en/publications/b221f526-6e44-4896-907c-6a5982a65d65
https://pure.eur.nl/en/publications/b221f526-6e44-4896-907c-6a5982a65d65
Autor:
Patrikidou A; Department of Oncology, Institut Gustave Roussy, Villejuif, France., Cazzaniga W; Department of Urology, The Royal Marsden NHS Foundation Trust, London, UK., Berney D; Barts Cancer Institute, Queen Mary University of London, London, UK., Boormans J; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Angst I; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Di Nardo D; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands., Fankhauser C; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland., Fischer S; Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Gravina C; Department of Urology, Sant'Andrea Hospital-Sapienza University, Rome, Italy., Gremmels H; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands., Heidenreich A; Department of Urology, Uniklinik Koln, Cologne, Germany., Janisch F; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Leão R; Department of Urology, Faculty of Medicine, University of Coimbra, Clinical Academic Center of Coimbra, Coimbra, Portugal., Nicolai N; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Oing C; Department of Oncology, Freeman Hospital NHS Foundation Trust, London, UK., Oldenburg J; Department of Oncology, Akershus University Hospital, Lorenskog, Norway., Shepherd R; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Tandstad T; Department of Oncology, The Cancer Clinic, St. Olav's University Hospital, Trondheim, Norway., Nicol D; Department of Urology, The Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer research, London, UK. Electronic address: david.nicol@rmh.nhs.uk.
Publikováno v:
European urology [Eur Urol] 2023 Sep; Vol. 84 (3), pp. 289-301. Date of Electronic Publication: 2023 May 12.